[MRI-guided brachytherapy in prostate cancer]

Area of Science:

• Oncology
• Radiation Oncology
• Urology

Background:

• Radiotherapy, including external beam and brachytherapy, is a common treatment for prostate cancer.
• A subset of patients experience local recurrence after initial radiotherapy.
• Historically, recurrent prostate cancer was managed with palliative hormonal therapy or whole-gland re-irradiation, often leading to significant adverse effects due to inadequate imaging for precise targeting.

Purpose of the Study:

• To introduce and describe the technique of focal salvage radiotherapy for localized recurrent prostate cancer.
• To highlight the advancements in imaging and radiotherapy that enable precise targeting of recurrent prostate cancer lesions.

Main Methods:

• Focal salvage radiotherapy involves precise targeting of the localized recurrent tumor within the prostate.
• Improvements in medical imaging (e.g., MRI, PET) allow for accurate delineation of recurrent lesions.
• Advanced radiotherapy techniques enable dose escalation to the recurrent site while sparing surrounding tissues.

Main Results:

• Focal salvage radiotherapy allows for treatment of localized recurrences previously managed with less precise methods.
• This technique aims to improve treatment efficacy for recurrent prostate cancer.
• Minimizing radiation dose to surrounding healthy tissues is a key benefit, potentially reducing toxicity.

Conclusions:

• Focal salvage radiotherapy represents an advancement in managing recurrent prostate cancer.
• Precise targeting of local recurrences can improve outcomes and reduce treatment-related morbidity.
• Further research and clinical evaluation are warranted to establish the long-term efficacy and safety of this approach.